Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers
Alexis B. Cortot(Centre Hospitalier Universitaire de Lille), David Tulasne(Centre National de la Recherche Scientifique)
Cited by 121
Related Papers
Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to Bedside
|Cancer Research|2014|68
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity
|Cell Death and Disease|2013|36